There has been some research suggesting that a type of type 2 diabetes drugs called SGLT2 inhibitors could reduce the incidence of some neurodegenerative conditions including Parkinson’s disease ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain ...

Sen. William Parkinson’s bill seeking aggravated murder, murder and manslaughter charges for meth and fentanyl dealers for ...

Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.

After researchers adjusted their data for factors that could affect the risk of dementia or Parkinson's disease—such as complications from diabetes and medications, age or kidney function—they ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as ...

Treatment of Parkinson’s disease is in large part based on the administration of Levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder similar ...

Novartis CEO Vas Narasimhan stated that the company will not compete in the "frenzy" of the weight loss drug market dominated ...

A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson's disease, signaling a ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...